Home > PE Ratio > MOREPEN LABORATORIES

MOREPEN LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of MOREPEN LABORATORIES is 31.34.

Share Price ₹53.3Sep 16,2025
Market Cap ₹2,922.5 Cr
Earnings-TTM₹93.3 CrTTM-Consolidated Results
Price/Earnings31.34xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results
MOREPEN LABORATORIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of MOREPEN LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MOREPEN LABORATORIES is calculated as :

Current Market Cap [ ₹2,922.5 Cr] as on Sep 16,2025

(/) Earnings [ ₹93.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 31.34x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MOREPEN LABORATORIES , the investors are currently willing to pay 31.34 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MOREPEN LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MOREPEN LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of MOREPEN LABORATORIES


PE Ratio Performance Analysis for MOREPEN LABORATORIES

- MOREPEN LABORATORIES 's latest p/e ratio is 31.34x.

- MOREPEN LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 22.12x.

- MOREPEN LABORATORIES 's operated at median p/e ratio of 22.21x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MOREPEN LABORATORIES 's p/e ratio peaked in Mar2023 at 33.94x.

- MOREPEN LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 14.89x.


How does MOREPEN LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MOREPEN LABORATORIES 93.2531.342,922.5
SUN PHARMACEUTICAL INDUSTRIES LTD10,411.5037.12386,497.0
DIVIS LABORATORIES LTD2,306.0070.16161,787.0
CIPLA LTD5,406.8123.28125,870.0
TORRENT PHARMACEUTICALS LTD2,002.0059.74119,591.0
DR REDDYS LABORATORIES LTD5,726.7019.10109,380.0
MANKIND PHARMA LTD1,905.5155.65106,044.0
ZYDUS LIFESCIENCES LTD4,637.8022.46104,145.0
LUPIN LTD3,722.1825.1793,694.0
AUROBINDO PHARMA LTD3,417.9318.5663,420.6
ABBOTT INDIA LTD1,452.2945.3165,799.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MOREPEN LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.56x
Max industry PE 70.16x
Median industry PE 31.34x
Average industry PE 37.08x



You may also like the below Video Courses